(July 24, 2020, 11:05 AM EDT) -- ALEXANDRIA, Va. — A Novo Nordisk patent relating to a formulation used in injection devices was "already disclosed" by prior art, Pfizer Inc. tells the Patent Trial and Appeal Board in a July 22 petition for inter partes review (IPR) (Pfizer Inc. v. Novo Nordisk A/S, No. IPR2020-01252, PTAB)....